BP000131-CYT-396: Recombinant Porcine Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of D10S cells is < 0.03 ng/ml.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000131-CYT-479: Recombinant Human Interleukin-1 alpha (IL-1α) Protein, His Tag
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000131-CYT-523: Recombinant Mouse Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine D10S cells is < 0.01 ng/ml, corresponding to a Specific Activity of 100,000,000 IU/mg.
Purity: > 98.0% by RP-HPLC and SDS-PAGE.BP000144-CYT-136: Recombinant Mouse Interleukin-1 Receptor Antagonist Protein (IL-1RA), His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGEBP000144-CYT-152: Recombinant Rat Interleukin-1 Receptor Antagonist Protein (IL-1RA)
Source: E. coli-derived.
Fully biologically active when compared to standard. Measured by its ability to inhibit IL1-dependent proliferation in D10.G4.1 mouse helper T cells. The ED50 for this effect is typically 30-150 ng/ml (corresponding to a specific activity of 6,667-33,334 units/mg ) in the presence of 50 pg/ml of rrIL1.
Purity: > 95.0% by SDS-PAGE.